Replies to post #27041 on Anavex Life Sciences Corp (AVXL)

[joshalex5]

Watch him get burned. They think there so smart. Maybe he should read about the science. He tweeted at the high that where he shorted my guess he covered same day at low. Anyway won't read his stuff. I believe in the science. Let's hope not 7 great news.

[WolfWayne]

Have you seen his most recent GIF?

[sokol]

If he and others like him were interested in the science, he would comment on that instead of fanning the flames for "another concerted short effort here". Instead, he comments in short syllable tweets that reveal nothing of any real value.

[Doktornolittle]

In Missling I trust to control even sharks. The truth is Missling is not an MD, he is a Ph.D.. He is a business man. A really gifted business man.

This deal does have a minor resemblance to some of the recent toxic deals I have seen, but it is truely a minor resemblance. The fact that the deal is done in $ instead of shares, and Lincoln gets shares at a 10% discount would setup a spiral down if Lincoln were just handed all the shares and let loose. Though the slope is very low, and there would be benefit to Lincoln to dump all at once. They would make less money. Perhaps most important, Missling would have no reason to do that. The whole point of the deal is that he can squeeze out shares when he wants, at the rate he wants, if he wants.

1) The 10% is a very low slope.
2) Missling stays in complete control of the release of shares.

10% is a very small discount. I looked at a recent deal by another popular small cap. The underwriter got 5%, and the investors got; the stock at a 27% discount to the RSP (my term "Recent Share Price") + 1/2 again warrants with an excercise price that was a 10% discount on the RSP. In comparison, this deal with Lincoln is squeeky clean! And that other biotech just did the deal as one big block, with the investors free to do whatever they want with the shares and warrants, whenever they want.

Basically, that other biotech gave a 30% discount to the investors and paid a 5% fee to the underwriter on top of that. All in all, only 65% efficient and no control whatsoever to how and when the shares got sold. Compare that to 100% control and a 90% efficiency that Missling set up. He's a frkn genius, and he must also have something that Lincoln likes.

Feurstein's job is to keep the price of small cap biotechs low so that Big Pharma can aquire them more easily at the point they feel satisfied that the risk is minimal. It is retail's job to take the high risk early on.

You have to understand that wealthy people don't take big risks. And people that are not super wealthy don't need money. If they want to gamble it away on risky biotechs, or buy lotto tickets at the local liquor store, then so be it. As long as they hand the lotto ticket (or small cap gem) over to the wealthy people if they get undeservedly lucky.